바이보심 랩스(VIVS)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.24 (-6.14%), 시가총액 $0.00B, PER (주가수익비율) 0.72, 52주 최저~최고 $1.27 ~ $4.78.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech co
바이보심 랩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
바이보심 랩스의 현재 주가는 $0.24 (-6.14%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
바이보심 랩스의 시가총액은 약 $0.00B입니다. PER은 0.72입니다.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers p